Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes. TEST

Date Filing Filing Description Download
January 22, 2020 SC 14D9/A Amended Statement of Ownership: Solicitation
January 22, 2020 SC TO-T/A Amended tender offer statement by Third Party
January 9, 2020 SC 14D9 Statement of Ownership: Solicitation


+0.01 +0.25% $ 3.99 Volume: 481,394 Common Stock | 20 minute delay January 21, 2020

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
Phone: 312.889.5244

Email Now